Ana Lucia S Rodrigues
Overview
Explore the profile of Ana Lucia S Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
3950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lapo-Talledo G, Montes-Escobar K, Rodrigues A, Siteneski A
J Affect Disord
. 2025 Jan;
374:433-442.
PMID: 39824314
Background: Sociodemographic characteristics and limited mental health care access may contribute to higher depression rates in low- and middle-income countries. This study aimed to analyze nationwide depressive disorder hospitalizations in...
2.
Kouba B, Rodrigues A
Pharmacol Biochem Behav
. 2024 Oct;
245():173899.
PMID: 39447683
The pathophysiology of a wide range of central nervous system (CNS) disorders, such as neurodegenerative and psychiatric diseases, has been associated with impairment of neurogenic and synaptogenic processes. Therefore, pharmacological...
3.
Kouba B, Alte G, Rodrigues A
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065743
Depression and anxiety disorders, prevalent neuropsychiatric conditions that frequently coexist, limit psychosocial functioning and, consequently, the individual's quality of life. Since the pharmacological treatment of these disorders has several limitations,...
4.
Kouba B, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues A
Cells
. 2024 Mar;
13(5.
PMID: 38474387
The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and...
5.
Borges de Souza P, de Araujo Borba L, Castro de Jesus L, Valverde A, Gil-Mohapel J, Rodrigues A
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069198
Major depressive disorder (MDD) has a high prevalence and is a major contributor to the global burden of disease. This psychiatric disorder results from a complex interaction between environmental and...
6.
Alte G, Rodrigues A
Pharmaceuticals (Basel)
. 2023 Jul;
16(7).
PMID: 37513925
Ketamine, a racemic mixture of esketamine (S-ketamine) and arketamine (R-ketamine), has received particular attention for its rapid antidepressant and antisuicidal effects. NMDA receptor inhibition has been indicated as one of...
7.
Camargo A, Dalmagro A, Alte G, Zeni A, Tasca C, Rodrigues A
Chem Biol Interact
. 2023 Mar;
375:110440.
PMID: 36878458
Guanosine has been reported to elicit antidepressant-like responses in rodents, but if these actions are associated with its ability to afford neuroprotection against glutamate-induced toxicity still needs to be fully...
8.
Kouba B, Camargo A, Rodrigues A
Metab Brain Dis
. 2023 Mar;
38(3):819-829.
PMID: 36862275
Alzheimer's disease (AD) is the most common cause of dementia. In recent years, several studies have robustly shown that neuroinflammation plays a crucial role in the pathophysiology of this disease....
9.
Kouba B, Gil-Mohapel J, Rodrigues A
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613574
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder, whose pathophysiology has been linked to the neuroinflammatory process. The increased activity of the Nod-like receptor pyrin containing protein 3...
10.
Kouba B, Torra A, Camargo A, Rodrigues A
Metab Brain Dis
. 2022 Nov;
38(2):601-611.
PMID: 36350480
Vitamin D (cholecalciferol) has been shown to exert antidepressant-like responses, but the role BDNF/TrkB-related synaptic plasticity in this effect remains to be established. Thus, this study investigated the time-course antidepressant-like...